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In the MMWR Recommendations and Reports "Human Papillomavirus Vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP)," an error occurred on page 5. The last sentence of the first full paragraph should read, "Among these six cancers, approximately **21,300** were attributable to HPV16/18 (**7,900 \[37%\]** among men and **13,400 \[63%\]** among women) ([Table 2](#t1-1182){ref-type="table"})."

In [Table 2](#t1-1182){ref-type="table"} on page 6, the average annual numbers of cancers attributable to HPV 16/18 were incorrect. Following is the corrected table:

###### 

Average annual number and percentage of cancer cases attributable to human papillomavirus and to HPV 16 and HPV 18, by anatomic site and sex --- United States, 2006--2010.

  Anatomic site   Average no. of cancers per year in sites where HPV is often found (HPV-associated cancers)[\*](#tfn2-1182){ref-type="table-fn"}   Cancers attributable to any HPV   Cancers attributable to HPV 16/18                                                                                                        
  --------------- --------------------------------------------------------------------------------------------------------------------------------- --------------------------------- ----------------------------------- ---------------------------------------- ------- -------- -------- -------- ----------- ------------ ------------
  Cervix          0                                                                                                                                 11,422                            11,422                              91[§](#tfn4-1182){ref-type="table-fn"}   0       10,400   10,400   67       0           **7,700**    **7,700**
  Anus            1,549                                                                                                                             2,821                             4,370                               91                                       1,400   2,600    4,000    **79**   **1,200**   **2,200**    **3,400**
  Oropharynx      9,974                                                                                                                             2,443                             12,417                              72                                       7,200   1,800    9,000    **62**   **6,200**   **1,500**    **7,700**
  Penis           1,048                                                                                                                             0                                 1,048                               63                                       700     0        700      48       **500**     0            **500**
  Vagina          0                                                                                                                                 735                               735                                 75                                       0       600      600      **57**   0           **400**      **400**
  Vulva           0                                                                                                                                 3,168                             3,168                               69                                       0       2,200    2,200    49       0           **1,600**    **1,600**
  Total           12,571                                                                                                                            20,589                            33,160                                                                       9,300   17,600   26,900            **7,900**   **13,400**   **21,300**

**Abbreviation:** HPV = human papillomavirus.

**Sources:** Data come from population-based cancer registries that participate in the National Program of Cancer Registries and/or the Surveillance, Epidemiology, and End Results Program, and meet criteria for high data quality. Cancer Registry Data are from all states meeting USCS publication criteria (<http://www.cdc.gov/cancer/npcr/uscs/technical_notes/criteria.htm>) for all years 2006--2010 and cover approximately 94.8% of the US population. In order to determine those cancers most likely to be HPV-associated, the following additional criteria were applied to the NPCR/SEER data: all cancers were microscopically confirmed**; c**ervical cancers were limited by histology to carcinomas only (ICD-O-3 histology codes 8010--8671, 8940--8941)**; a**ll other cancer sites were limited by histology to squamous cell carcinomas only (ICD-O-3 histology codes 8050--8084,8120--8131)**; o**ropharyngeal cancers were defined as having the following ICD-O-3 site codes: 19, 24, 28, 90--91, 98--99, 102, 108--109, 140, 142, and 148.

The estimated number of HPV-attributable or HPV 16/18-attributable cancers was calculated by multiplying the HPV-associated cancer counts by the percentage of each cancer attributable to HPV or HPV16/18. Estimates rounded to the nearest 100.

Although HPV is accepted to be a necessary factor in the causal pathway to invasive cervical cancer, HPV is not always detected in tumor specimens from women who receive a diagnosis of invasive cervical cancer due to a variety of reasons, including misclassification of tissue specimens as cervix, quality of tissue specimens, assay sensitivity, and a small proportion of HPV-negative, cervical cancers.
